nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromhexine—Angioedema—Rosuvastatin—atherosclerosis	0.0269	0.0269	CcSEcCtD
Bromhexine—Immune system disorder—Ezetimibe—atherosclerosis	0.0254	0.0254	CcSEcCtD
Bromhexine—Angioedema—Lovastatin—atherosclerosis	0.0228	0.0228	CcSEcCtD
Bromhexine—Angioedema—Ezetimibe—atherosclerosis	0.0224	0.0224	CcSEcCtD
Bromhexine—Angioedema—Simvastatin—atherosclerosis	0.0213	0.0213	CcSEcCtD
Bromhexine—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.0207	0.0207	CcSEcCtD
Bromhexine—Anaphylactic shock—Lovastatin—atherosclerosis	0.0204	0.0204	CcSEcCtD
Bromhexine—Anaphylactic shock—Ezetimibe—atherosclerosis	0.02	0.02	CcSEcCtD
Bromhexine—Angioedema—Niacin—atherosclerosis	0.0196	0.0196	CcSEcCtD
Bromhexine—Skin disorder—Ezetimibe—atherosclerosis	0.0194	0.0194	CcSEcCtD
Bromhexine—Angioedema—Pravastatin—atherosclerosis	0.0193	0.0193	CcSEcCtD
Bromhexine—Urticaria—Rosuvastatin—atherosclerosis	0.0191	0.0191	CcSEcCtD
Bromhexine—Anaphylactic shock—Simvastatin—atherosclerosis	0.0191	0.0191	CcSEcCtD
Bromhexine—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.0181	0.0181	CcSEcCtD
Bromhexine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.0177	0.0177	CcSEcCtD
Bromhexine—Anaphylactic shock—Niacin—atherosclerosis	0.0175	0.0175	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.0172	0.0172	CcSEcCtD
Bromhexine—Anaphylactic shock—Pravastatin—atherosclerosis	0.0172	0.0172	CcSEcCtD
Bromhexine—Pruritus—Rosuvastatin—atherosclerosis	0.017	0.017	CcSEcCtD
Bromhexine—Skin disorder—Niacin—atherosclerosis	0.017	0.017	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.0164	0.0164	CcSEcCtD
Bromhexine—Diarrhoea—Rosuvastatin—atherosclerosis	0.0164	0.0164	CcSEcCtD
Bromhexine—Urticaria—Lovastatin—atherosclerosis	0.0162	0.0162	CcSEcCtD
Bromhexine—Urticaria—Ezetimibe—atherosclerosis	0.0159	0.0159	CcSEcCtD
Bromhexine—Rash—Rosuvastatin—atherosclerosis	0.0152	0.0152	CcSEcCtD
Bromhexine—Dermatitis—Rosuvastatin—atherosclerosis	0.0151	0.0151	CcSEcCtD
Bromhexine—Urticaria—Simvastatin—atherosclerosis	0.0151	0.0151	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Niacin—atherosclerosis	0.0151	0.0151	CcSEcCtD
Bromhexine—Hypersensitivity—Lovastatin—atherosclerosis	0.015	0.015	CcSEcCtD
Bromhexine—Hypersensitivity—Ezetimibe—atherosclerosis	0.0147	0.0147	CcSEcCtD
Bromhexine—Pruritus—Lovastatin—atherosclerosis	0.0144	0.0144	CcSEcCtD
Bromhexine—Nausea—Rosuvastatin—atherosclerosis	0.0143	0.0143	CcSEcCtD
Bromhexine—Pruritus—Ezetimibe—atherosclerosis	0.0141	0.0141	CcSEcCtD
Bromhexine—Hypersensitivity—Simvastatin—atherosclerosis	0.014	0.014	CcSEcCtD
Bromhexine—Diarrhoea—Lovastatin—atherosclerosis	0.0139	0.0139	CcSEcCtD
Bromhexine—Urticaria—Niacin—atherosclerosis	0.0139	0.0139	CcSEcCtD
Bromhexine—Urticaria—Pravastatin—atherosclerosis	0.0137	0.0137	CcSEcCtD
Bromhexine—Diarrhoea—Ezetimibe—atherosclerosis	0.0137	0.0137	CcSEcCtD
Bromhexine—Pruritus—Simvastatin—atherosclerosis	0.0135	0.0135	CcSEcCtD
Bromhexine—Diarrhoea—Simvastatin—atherosclerosis	0.013	0.013	CcSEcCtD
Bromhexine—Vomiting—Lovastatin—atherosclerosis	0.0129	0.0129	CcSEcCtD
Bromhexine—Hypersensitivity—Niacin—atherosclerosis	0.0129	0.0129	CcSEcCtD
Bromhexine—Rash—Lovastatin—atherosclerosis	0.0128	0.0128	CcSEcCtD
Bromhexine—Dermatitis—Lovastatin—atherosclerosis	0.0128	0.0128	CcSEcCtD
Bromhexine—Vomiting—Ezetimibe—atherosclerosis	0.0127	0.0127	CcSEcCtD
Bromhexine—Hypersensitivity—Pravastatin—atherosclerosis	0.0127	0.0127	CcSEcCtD
Bromhexine—Rash—Ezetimibe—atherosclerosis	0.0126	0.0126	CcSEcCtD
Bromhexine—Dermatitis—Ezetimibe—atherosclerosis	0.0126	0.0126	CcSEcCtD
Bromhexine—Pruritus—Niacin—atherosclerosis	0.0124	0.0124	CcSEcCtD
Bromhexine—Pruritus—Pravastatin—atherosclerosis	0.0122	0.0122	CcSEcCtD
Bromhexine—Vomiting—Simvastatin—atherosclerosis	0.0121	0.0121	CcSEcCtD
Bromhexine—Nausea—Lovastatin—atherosclerosis	0.0121	0.0121	CcSEcCtD
Bromhexine—Rash—Simvastatin—atherosclerosis	0.012	0.012	CcSEcCtD
Bromhexine—Dermatitis—Simvastatin—atherosclerosis	0.012	0.012	CcSEcCtD
Bromhexine—Diarrhoea—Niacin—atherosclerosis	0.012	0.012	CcSEcCtD
Bromhexine—Nausea—Ezetimibe—atherosclerosis	0.0119	0.0119	CcSEcCtD
Bromhexine—Diarrhoea—Pravastatin—atherosclerosis	0.0118	0.0118	CcSEcCtD
Bromhexine—Nausea—Simvastatin—atherosclerosis	0.0113	0.0113	CcSEcCtD
Bromhexine—Vomiting—Niacin—atherosclerosis	0.0111	0.0111	CcSEcCtD
Bromhexine—Rash—Niacin—atherosclerosis	0.011	0.011	CcSEcCtD
Bromhexine—Dermatitis—Niacin—atherosclerosis	0.011	0.011	CcSEcCtD
Bromhexine—Vomiting—Pravastatin—atherosclerosis	0.011	0.011	CcSEcCtD
Bromhexine—Rash—Pravastatin—atherosclerosis	0.0109	0.0109	CcSEcCtD
Bromhexine—Dermatitis—Pravastatin—atherosclerosis	0.0108	0.0108	CcSEcCtD
Bromhexine—Nausea—Niacin—atherosclerosis	0.0104	0.0104	CcSEcCtD
Bromhexine—Nausea—Pravastatin—atherosclerosis	0.0102	0.0102	CcSEcCtD
